CN110251841A - 用于光治疗的波长配置方法、光源配置方法、一种光源 - Google Patents
用于光治疗的波长配置方法、光源配置方法、一种光源 Download PDFInfo
- Publication number
- CN110251841A CN110251841A CN201910511312.1A CN201910511312A CN110251841A CN 110251841 A CN110251841 A CN 110251841A CN 201910511312 A CN201910511312 A CN 201910511312A CN 110251841 A CN110251841 A CN 110251841A
- Authority
- CN
- China
- Prior art keywords
- light
- wavelength
- survival rate
- human body
- stimulus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 53
- 230000004083 survival effect Effects 0.000 claims abstract description 83
- 230000002538 fungal effect Effects 0.000 claims abstract description 69
- 241000233866 Fungi Species 0.000 claims abstract description 24
- 238000012360 testing method Methods 0.000 claims abstract description 22
- 230000001954 sterilising effect Effects 0.000 claims abstract description 18
- 210000004027 cell Anatomy 0.000 claims description 124
- 230000000694 effects Effects 0.000 claims description 19
- 230000000153 supplemental effect Effects 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000002474 experimental method Methods 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 238000004020 luminiscence type Methods 0.000 claims description 7
- 210000005260 human cell Anatomy 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241001478240 Coccus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229960000282 metronidazole Drugs 0.000 description 3
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010004074 Balanitis candida Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 1
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 244000154870 Viola adunca Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000005035 cutaneous candidiasis Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910511312.1A CN110251841B (zh) | 2019-06-13 | 2019-06-13 | 用于光治疗的波长配置方法、光源配置方法、一种光源 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910511312.1A CN110251841B (zh) | 2019-06-13 | 2019-06-13 | 用于光治疗的波长配置方法、光源配置方法、一种光源 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110251841A true CN110251841A (zh) | 2019-09-20 |
CN110251841B CN110251841B (zh) | 2021-05-04 |
Family
ID=67918114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910511312.1A Active CN110251841B (zh) | 2019-06-13 | 2019-06-13 | 用于光治疗的波长配置方法、光源配置方法、一种光源 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110251841B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101355983A (zh) * | 2005-08-03 | 2009-01-28 | 诺密尔医药技术公司 | 结合医疗设备使用的近红外除菌激光系统(nimels) |
EP1833502B1 (en) * | 2004-12-23 | 2011-03-02 | Council of Scientific and Industrial Research | Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
CN107613895A (zh) * | 2015-06-03 | 2018-01-19 | 纽约市哥伦比亚大学托管会 | 选择性地影响和/或杀灭病毒的设备、方法及系统 |
-
2019
- 2019-06-13 CN CN201910511312.1A patent/CN110251841B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1833502B1 (en) * | 2004-12-23 | 2011-03-02 | Council of Scientific and Industrial Research | Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
CN101355983A (zh) * | 2005-08-03 | 2009-01-28 | 诺密尔医药技术公司 | 结合医疗设备使用的近红外除菌激光系统(nimels) |
CN107613895A (zh) * | 2015-06-03 | 2018-01-19 | 纽约市哥伦比亚大学托管会 | 选择性地影响和/或杀灭病毒的设备、方法及系统 |
Non-Patent Citations (1)
Title |
---|
DAI TIANHONG: ""Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action"", 《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110251841B (zh) | 2021-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Soukos et al. | Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model | |
Gudkov et al. | Effect of visible light on biological objects: Physiological and pathophysiological aspects | |
US20050059731A1 (en) | Erythrosin-based antimicrobial photodynamic therapy compound and its use | |
Jia et al. | Wireless opto-electro neural interface for experiments with small freely behaving animals | |
US20220257930A1 (en) | Systems and Methods for the Treatment of Oral and Systemic maladies in Animals Using Electrical Current | |
Kang et al. | Susceptibility of oral bacteria to antibacterial photodynamic therapy | |
JP2007503917A (ja) | 抗菌性光力学治療化合物およびその使用方法 | |
CN110812482A (zh) | 一种活生物自产氧光敏剂及其应用 | |
CN110251841A (zh) | 用于光治疗的波长配置方法、光源配置方法、一种光源 | |
CN1102333A (zh) | 鱼菌灵 | |
Spinei et al. | The antimicrobial activity of photodynamic therapy against Streptococci species in dental biofilm using different photosensitizers: An in vitro study | |
CN113286563B (zh) | 用于在口腔和咽腔中激发荧光和照射微生物的手持设备 | |
AU2014364214B2 (en) | Concurrent treatment of oral and systemic maladies in animals using electrical current | |
KR20170100266A (ko) | 청색 led를 이용한 어류의 스쿠티카증의 예방 및 치료 방법 | |
Serrage et al. | Spectral Characterization of a Blue Light-Emitting Micro-LED Platform and Microbial Chromophores for Therapeutic Applications in Skin Conditions | |
Du et al. | Electroluminodynamic therapy for the treatment of drug-resistant pathogen infection | |
Astuti et al. | Antimicrobial Photodynamic Effectiveness of Light Emitting Diode (Led) For Inactivation on Staphylococcus aureus Bacteria and Wound Healing in Infectious Wound Mice | |
CN204910518U (zh) | 用于治疗牙周炎的光子治疗仪 | |
CN109091685A (zh) | 一种对角膜炎提取细菌病原体的灭活方法 | |
CN107626046A (zh) | 用于头部脓肿性穿掘性毛囊周围炎的光治疗装置及方法 | |
CN202875777U (zh) | 多功能臭氧治疗仪 | |
El-Shafii | Impact of low light laser therapy (LLLT) on microorganisms causing subclinical and clinical bovine mastitis | |
Matera et al. | Photoswitchable molecular prosthetics to photocontrol auditory neurons | |
Biradar et al. | Oral biofilm-a review | |
AL-ZAHAWI et al. | The Roll of Low Level Laser in Diarrhoea treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 215163 Suzhou 88 high tech Zone, Jiangsu science and Technology City Patentee after: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Patentee after: Nanjing Guoke Precision Medical Technology Co.,Ltd. Address before: 215163 Suzhou 88 high tech Zone, Jiangsu science and Technology City Patentee before: Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Patentee before: NANJING GUOKE MEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |